Related Experiment Video
Updated: Jul 11, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
RGFP966 inhibits palmitic acid induced VSMCs phenotypic transition by targeting ATGL
Siyi Zhang1, Fangqin Nie1, Youjie Zeng2
1Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Insights
RGFP966, an HDAC3 inhibitor, protects against vascular smooth muscle cell (VSMC) transitions by regulating Adipose triglyceride lipase (ATGL). This offers a potential therapeutic strategy for cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Cellular Mechanisms
- Pharmacology
Background:
- Vascular smooth muscle cell (VSMC) phenotypic switching is central to cardiovascular disease pathology.
- Histone deacetylase 3 (HDAC3) is upregulated in cardiovascular diseases.
- RGFP966 is a selective HDAC3 inhibitor.
Purpose of the Study:
- To investigate the effects of RGFP966 on VSMC phenotypic switching.
- To explore the underlying molecular mechanisms.
Main Methods:
- Analysis of HDAC3 expression in Gene Expression Omnibus (GEO) datasets.
- Cellular assays including CCK-8, Edu, and wound healing to assess VSMC proliferation and migration.
- Investigated the role of Adipose triglyceride lipase (ATGL) and the mTOR pathway.
Main Results:
- Palmitic acid (PA) induced lipid droplet accumulation, downregulated ATGL, and increased VSMC viability and migration.
- RGFP966 reversed PA-induced changes in VSMCs.
- siRNA targeting ATGL exacerbated PA-induced injury, while 3-Methyladenine (3-MA) partially reversed PA-induced ATGL decrease.
- PA decreased the p-mTOR/mTOR ratio, which rebounded with RGFP966 treatment.
Conclusions:
- RGFP966 exhibits a protective effect against VSMC phenotypic transitions.
- This protection is potentially mediated through the regulation of ATGL.
- HDAC3 inhibition may represent a therapeutic target for cardiovascular diseases involving VSMC dysfunction.
Background:
The phenotypic switch of vascular smooth muscle cells (VSMCs) underlies the pathology of many cardiovascular diseases. Histone deacetylase 3 (HDAC3) is reported to upregulate in several cardiovascular diseases. RGFP966 is a highly selective HDAC3 inhibitor. This study aimed to explore the effects of RGFP966 on the phenotypic switch of VSMCs.
Method:
First, we conducted an analysis of HDAC3 expression utilizing pertinent Gene Expression Omnibus (GEO) datasets. Then CCK-8, Edu, and wound healing assays were used to explore the effects of RGFP966 on the proliferation and migration of VSMCs and potential mechanisms at the cellular level.
Results:
Our results showed that palmitic acid (PA) induced the accumulation of lipid droplets in VSMCs, downregulated Adipose triglyceride lipase (ATGL), and increased VSMC viability and migration, which were significantly reversed by RGFP966. Additionally, siRNA targeting ATGL dramatically enhanced the VSMCs injury induced by PA. The autophagy inhibitor 3-Methyladenine (3-MA) partially reversed the decreased ATGL expression caused by PA. Furthermore, the p-mTOR/mTOR ratio decreased under PA induction and rebounded after administration of RGFP966.
Conclusion:
RGFP966 has a protective effect against VSMCs phenotype transitions, potentially related to the regulation of ATGL.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of the Unfolded Protein Response
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...

